商用放射组学软件与自研放射组学软件在胰腺导管腺癌与健康对照CT图像分类中的诊断性能比较
本研究回顾性纳入190例胰腺导管腺癌患者与190例健康对照,从术前CT手动分割胰腺并提取放射组学特征,比较商用研究原型与自研软件在随机森林二分类中的诊断性能。使用40个特征时,自研软件敏感度1.00、准确率0.992,商用原型敏感度0.950、准确率0.968;特征减至5个时自研软件性能下降,商用原型不变。结论认为两者诊断性能相似,可能降低放射组学研究门槛。
要点
- 40个特征时自研软件敏感度1.00、准确率0.992,商用原型敏感度0.950、准确率0.968。
- 特征减至5个时自研软件敏感度0.950、特异度0.923、准确率0.936,商用原型不变。
- 商用与自研放射组学软件诊断性能相似,可能降低放射组学研究入门门槛。
核心结论
- 商用与自研放射组学软件在胰腺导管腺癌与健康对照的CT图像二分类中达到相似的诊断性能。
- 该结果可能降低放射组学研究的入门门槛,使更多临床科学家能够开展放射组学研究。
研究设计与样本
- 回顾性病例对照研究,纳入190例胰腺导管腺癌患者(97男、93女,66±9岁,2012至2017年)和190例无已知胰腺疾病的健康潜在肾捐献者(96男、94女,52±8岁,2005至2009年)。
- 从术前CT手动分割胰腺3D容积,自研放射组学软件提取478个特征,商用研究原型提取854个特征。
- 采用随机森林分类器进行胰腺导管腺癌与正常胰腺的二分类,比较商用软件与自研软件的准确率、敏感度和特异度。
诊断标准与关键数值
- 使用40个特征时,自研软件敏感度1.00、准确率0.992,商用研究原型敏感度0.950、准确率0.968。
- 特征数减至5个时,自研软件敏感度0.950、特异度0.923、准确率0.936,商用研究原型诊断性能不变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this study is to evaluate diagnostic performance of a commercially available radiomics research prototype vs. an in-house radiomics software in the binary classification of CT images from patients with pancreatic ductal adenocarcinoma (PDAC) vs. healthy controls.
MATERIALS AND METHODS: In this retrospective case-control study, 190 patients with PDAC (97 men, 93 women; 66 ± 9 years) from 2012 to 2017 and 190 healthy potential renal donors (96 men, 94 women; 52 ± 8 years) without known pancreatic disease from 2005 to 2009 were identified from radiology and pathology databases. 3D volume of the pancreas was manually segmented from preoperative CT scans. Four hundred and seventy-eight radiomics features were extracted using in-house radiomics software. Eight hundred and fifty-four radiomics features were extracted using a commercially available research prototype. Random forest classifier was used for binary classification of PDAC vs. normal pancreas. Accuracy, sensitivity, and specificity of commercially available radiomics software were compared to in-house software.
RESULTS: When 40 radiomics features were used in the random forest classification, in-house software achieved superior sensitivity (1.00) and accuracy (0.992) compared to the commercially available research prototype (sensitivity = 0.950, accuracy = 0.968). When the number of features was reduced to five features, diagnostic performance of the in-house software decreased to sensitivity (0.950), specificity (0.923), and accuracy (0.936). Diagnostic performance of the commercially available research prototype was unchanged.
CONCLUSION: Commercially available and in-house radiomics software achieve similar diagnostic performance, which may lower the barrier of entry for radiomics research and allow more clinician-scientists to perform radiomics research.
引用
- Chu LC, Solmaz B, Park S, et al. Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls. Abdom Radiol (NY). 2020. PMID: 32372206. doi:10.1007/s00261-020-02556-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。